Tariffs

News

Roche joins the pharma firms planning big US investments

Roche will spend $50bn on manufacturing and R&D facilities in the US, with a pledge to export more medicines from the US than it imports.

News

Tariffs spelled out with Scrabble letters

Tariffs 'could cancel out discounts with biosimilars'

Tariffs on US pharma imports could remove discounts offered to health systems by biosimilars and threaten the future of the sector, says a non-profit.

News

J&J expecting $400m hit from tariffs in 2025

J&J chief executive Joaquin Duato has told analysts that tax policy, not tariffs, is the key to increasing pharma manufacturing capacity in the US.

News

US starts the clock ticking on pharma tariffs

The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.

News

Novartis radioligand therapy (RLT) manufacturing facility

Novartis plans $23bn manufacturing, R&D spend in US

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.

Market Access

Reuters Europe 2025: Trade-offs in European launch sequencin...

At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.

Roche joins the pharma firms planning big US investments

Tariffs 'could cancel out discounts with biosimilars'

J&J expecting $400m hit from tariffs in 2025

US starts the clock ticking on pharma tariffs

Novartis plans $23bn manufacturing, R&D spend in US

Reuters Europe 2025: Trade-offs in European launch sequencin...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Tariffs

Editor's Picks